BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/6/2021 7:03:21 AM | Browse: 567 | Download: 1256
 |
Received |
|
2021-03-30 03:49 |
|
Peer-Review Started |
|
2021-04-01 02:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-08 07:22 |
|
Revised |
|
2021-07-18 02:51 |
|
Second Decision |
|
2021-07-22 03:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-07-22 09:21 |
|
Articles in Press |
|
2021-07-22 09:21 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-30 01:23 |
|
Typeset the Manuscript |
|
2021-08-06 02:54 |
|
Publish the Manuscript Online |
|
2021-08-06 07:03 |
| ISSN |
2220-6124 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Retrospective Cohort Study |
| Article Title |
Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Maria Goretti Moreira Guimarães Penido and Marcelo de Sousa Tavares |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Maria Goretti Moreira Guimarães Penido, FRCP (Hon), MD, PhD, Associate Professor, Chief Doctor, Professor, Pediatric Nephrology Unit, Nephrology Center of Santa Casa de Belo Horizonte, Rua Piauí 420, Santa Efigênia, Belo Horizonte 30150320, Minas Gerais, Brazil. mariagorettipenido@yahoo.com.br |
| Key Words |
Children; Adolescent; Hypercalciuria; Bone mineral density; Thiazides; Citrate |
| Core Tip |
Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents? Reduction in bone mass has already been described in hypercalciuric pediatric patients and the precise mechanisms of bone loss or failure to achieve adequate bone mass remain unknown. Initial recommendations for the treatment of hypercalciuric pediatric patients consist of lifestyle changes and adequate diet. Children rarely comply with those recommendations and require potassium citrate supplementation or thiazides to reduce calciuria. However, anticalciuric therapy in children and adolescents is not based on strong clinical evidences. We speculate if the anticalciuric effect of pharmacologic therapy has a beneficial role on bone mass in pediatric idiopathic hypercalciuria and compromised bone mass in adulthood. |
| Publish Date |
2021-08-06 07:03 |
| Citation |
Penido MGMG, Tavares MS. Should pediatric idiopathic hypercalciuria be treated with hypocalciuric agents? World J Nephrol 2021; 10(4): 47-58 |
| URL |
https://www.wjgnet.com/2220-6124/full/v10/i4/47.htm |
| DOI |
https://dx.doi.org/10.5527/wjn.v10.i4.47 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
